Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Real World Study of Rimegepant in the Treatment of Migraine

NCT05709106 is registered in ClinicalTrials.gov with Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine as lead sponsor.

NCT NCT05709106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Real World Study of Rimegepant in the Treatment of Migraine
Lead sponsor
Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine
Phase
Observational
Overall status
Completed
Start date
January 11, 2023
Completion date
April 9, 2025
Enrollment
173 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine